Skip to main content
Open access
Commentary
Published Online: 26 April 2017

Adolescents “Dabbing” With Marijuana: A Novel Mechanism for Smoking Highly Concentrated Tetrahydrocannabinol

Publication: American Journal of Psychiatry Residents' Journal
The legalization of marijuana and decriminalization of its possession across America has likely contributed to the public’s view of marijuana as a relatively safe drug (1, 2). Marijuana is still the most widely abused drug among adolescents (1). Yet, public health campaigns depicting the harms associated with adolescent marijuana use, such as increased rates of psychosis in teenagers with a predisposition for schizophrenia and a dose-dependent increase in rates of suicide attempts, have not kept pace with legalization (1). Although epidemiologic data are sparse and inconsistent, there is evidence that the rates of youth marijuana abuse increase postlegalization (1, 3). Given peer pressure and access to drugs in this population, novel mechanisms for ingestion, like dabbing, may be used earlier and more frequently by adolescents.
Dabbing is a mode of marijuana ingestion in which individuals inhale a highly concentrated form of tetrahydrocannabinol (THC) from vaporized butane hash oil (colloquially called dabs, earwax, budder, shatter) created via butane extraction (3). Dabs contain THC concentrations up to 23%–80%, compared to the 3%–6% seen in traditionally smoked cannabis (2, 4, 5). Up to 40% of the THC can be inhaled, based on controlled experiments (4). Recreational users can synthesize dabs at home through a process known as blasting, with directions easily found via Internet search (2, 3).
Dabbing brings up several safety concerns, primarily dangers inherent to blasting, potential contamination of homemade dabs, and an increased risk of addiction and psychosis associated with the highly concentrated THC vapors (2, 4, 5). The safety of at-home blasting has been compared to that of home methamphetamine labs due to butane’s highly flammable and volatile nature (3). Blasting has resulted in several documented cases of fires, explosions, and severe burns (3).
Advocates of dabbing argue that this preparation of THC eliminates dangerous bacteria, mold, fungi, and other toxic compounds found in traditionally smoked cannabis (3). However, a recent study examining 57 dab concentrates available for consumption in the California medical cannabis market found that 80% were contaminated by considerable amounts of residual solvent, most commonly isopentane, and less frequently pesticides, like paclobutrazol and bifenthrin (4).
In 2014, Loflin and Earleywine (2) reported that 357 surveyed dab users, ranging from 18–71 years of age, preferred dabbing over smoking traditional cannabis due to the potency of dabs. The high was described by users as “stronger” and “qualitatively different.” However, the authors also found that dabbing was associated with statistically significant increases in subjective withdrawal and tolerance symptoms, suggesting that dabbing could have a greater addictive potential than traditional smoking (2, 3).
Because of this growing trend, increasing numbers of patients will likely present to emergency room settings with acute marijuana wax intoxication. At least one case of butane hash oil-induced psychosis that did not respond to an antipsychotic has been reported in the literature (5). It is unclear whether dabbing-induced psychosis is transient or could lead to chronic psychotic illness in vulnerable patients. Because dabs can be easily made at home following online tutorials and most adults would not recognize these small, waxy resins as marijuana, adolescents may be at particularly high risk of experimenting with dabbing and subsequently experiencing its negative consequences.

References

1.
Committee on Substance Abuse, Committee on Adolescence: The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics 2015; 135:584–587
2.
Loflin M, Earleywine M: A new method of cannabis ingestion: the dangers of dabs? Addict Behav 2014; 29:1430–1433
3.
Wall MM, Poh E, Cerda M, et al: Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann Epidemiol 2011; 21:714–716
4.
Raber JC, Elzinga S, Kaplan C: Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J Toxicol Sci 2015; 40:797–803
5.
Keller CJ, Chen EC, Brodsky K, et al: A case of butane hash oil (marijuana wax)-induced psychosis. Subst Abus (Epub ahead of print, Jan 28, 2016)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry Residents' Journal
American Journal of Psychiatry Residents' Journal
Pages: 12

History

Published in print: June 01, 2016
Published online: 26 April 2017

Authors

Affiliations

Katrina Furey, M.D.
Dr. Furey is a second-year resident in the Department of Psychiatry, Yale-New Haven Hospital, New Haven, Conn.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share